Mediators of Inflammation / 2015 / Article / Tab 2 / Review Article
Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update Table 2 Recently reported MMP inhibitors in models of intestinal inflammation. Novel MMP inhibitors, plant extracts tested in IBD models, and existing IBD therapies are included where MMP-9 expression or activity has been measured.
MMP inhibitor MMPs inhibited Model Reference RO28-2653 MMP-2, -9 DSS (mouse) (acute) [163 ] Ilomastat MMP-1 TNBS (rat) [173 ] Minocycline MMP-2, -3, -9, -13 DSS or TNBS (mouse) [172 ] Etiasa (mesalazine) MMP-2 TNBS (rat) [30 ] Irsogladine maleate MMP-2 DSS (mouse) [209 ] Infliximab MMP-1, -2, -3, -9, -13 Human CD (serum and biopsy) [174 , 175 ] CC-10004 MMP-3 Mononuclear cells from human CD [165 ] Nitrate-barbiturates MMP-9 Cytokine stimulated Caco-2 cells [161 ] Auraptene MMP-7, -2, -9 DSS (mouse) [180 ] coumarin 4-methylesculetin MMP-9 TNBS (rat) [181 ] Tris(methoxymethoxy)chalcone MMP-7 TNF-α stimulated HT-29 cells [182 ] Curcumin MMP-3 Cultured colonic myofibroblasts from IBD patients [183 ] Phenylpropanoid glycosides: teupolioside and verbascoside MMP-2, -9 DNBS (rat) [184 , 185 ] Neovastat MMP-9 TNBS (rat) [188 ] Α lpha-lipoicMMP-9 DSS (mouse) [210 ] Cordyceps militaris MMP-3 and -9 DSS (mouse) [189 ] Calcium (CaHPO4 ) MMP-9, -10, -13 HLA-B27 transgenic rat [190 ]